DIN 02537974 — APO-ESLICARBAZEPINE 800 MG
APO-ESLICARBAZEPINE is a tablet of Eslicarbazepine Acetate marketed by APOTEX INC. The full Eslicarbazepine Acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02537974
- Brand name
- APO-ESLICARBAZEPINE
- Active ingredient
- Eslicarbazepine Acetate
- Strength
- 800 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Voltage-gated sodium channel blocker (antiepileptic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Eslicarbazepine Acetate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02537931 | APO-ESLICARBAZEPINE | 200 MG | TABLET | APOTEX INC | MARKETED |
| 02537958 | APO-ESLICARBAZEPINE | 400 MG | TABLET | APOTEX INC | MARKETED |
| 02537966 | APO-ESLICARBAZEPINE | 600 MG | TABLET | APOTEX INC | MARKETED |
| 02527421 | AURO-ESLICARBAZEPINE | 200 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02527448 | AURO-ESLICARBAZEPINE | 400 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02527456 | AURO-ESLICARBAZEPINE | 600 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02527464 | AURO-ESLICARBAZEPINE | 800 MG | TABLET | AURO PHARMA INC | MARKETED |